Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Bought by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lifted its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 1.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,342 shares of the medical instruments supplier’s stock after acquiring an additional 400 shares during the quarter. Illinois Municipal Retirement Fund owned 0.05% of Merit Medical Systems worth $2,935,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC increased its position in Merit Medical Systems by 32.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the period. Harvest Fund Management Co. Ltd purchased a new position in Merit Medical Systems in the third quarter worth $120,000. GAMMA Investing LLC lifted its holdings in Merit Medical Systems by 14.7% in the fourth quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier’s stock valued at $144,000 after acquiring an additional 191 shares during the period. TD Private Client Wealth LLC boosted its position in shares of Merit Medical Systems by 13.9% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier’s stock worth $171,000 after purchasing an additional 211 shares in the last quarter. Finally, Ballentine Partners LLC acquired a new position in shares of Merit Medical Systems during the 4th quarter worth $200,000. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Trading Down 1.9 %

MMSI opened at $98.52 on Friday. Merit Medical Systems, Inc. has a 52-week low of $70.70 and a 52-week high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $5.74 billion, a P/E ratio of 48.29, a P/E/G ratio of 2.34 and a beta of 0.87. The firm’s 50 day moving average is $102.83 and its 200-day moving average is $99.88.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Needham & Company LLC dropped their price objective on Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating for the company in a research note on Wednesday. Wells Fargo & Company decreased their price objective on shares of Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating on the stock in a research report on Wednesday. Raymond James raised their target price on shares of Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Tuesday, December 31st. Piper Sandler reaffirmed an “overweight” rating and issued a $116.00 price target (up previously from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Finally, Barrington Research dropped their price objective on shares of Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating for the company in a research note on Wednesday. Two analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $108.40.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.